Clinical Trial Update: The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the effect of post-ablation medroxyprogesterone acetate on endometrial amenorrhea rates was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia

Drugs mentioned

• Medroxyprogesterone acetate (Medroxyprogesterone acetate)

Snippet

Sponsor: Guy Waddell | Conditions: Menorrhagia | Phase 3 | Status: TERMINATED